|
New Cavity-Fighting Agent Shows Promise
Excerpt
By Keith Mulvihill, Reuters Health
An experimental cavity-fighting toothpaste
may be better at preventing tooth decay and cavities than traditional
fluoride toothpaste, according to a study.
The new agent does not contain
any fluoride, which has been the cornerstone of cavity prevention
for decades.
The product, called CaviStat, contains
the amino acid arginine as well as calcium carbonate. The toothpaste
may help fight cavities by promoting a higher pH in the mouth,
according to Mitchell Goldberg, president of Ortek Therapeutics
Inc., the company granted the licensing rights to the product
by the Research Foundation of the State University of New York.
After eating food, the bacteria
trapped in sticky plaque inside the mouth metabolize sugars and
release acid. Over time, this process can eat away at the enamel
of the tooth and promote decay.
The study, which is due to be presented
at the International Association of Dental Research in Sweden
later this week, suggests the calcium carbonate portion of the
CaviStat might also remineralize teeth at a higher rate than fluoride,
explained Goldberg in an interview.
Dr. Dan Meyer, director of science
at the American Dental Association characterized his reaction
to the study as "guardedly optimistic." He said he hasn't actually
evaluated the product.
"Normally, you like to have several
studies that find similar results," he said, adding that the current
study "shows promise," but more research is needed to validate
the anti-cavity findings.
In the study, Dr. Israel Kleinberg,
of Stony Brook University in New York, and colleagues evaluated
the efficacy of CaviStat among 726 Venezuelan children who were
between 10 and 11 years old.
Half of the youngsters were instructed
to brush their teeth three times a day for one minute with CaviStat
toothpaste, and the other used traditional fluoride toothpaste.
After one year, CaviStat appeared
to reduce the signs of early tooth decay, according to Goldberg.
At the end of two years, kids who
used CaviStat had fewer cavities compared to the ones in the fluoride
group, said Goldberg.
Although this is the first large
clinical trial of the product to be conducted, Goldberg said he
is confident that future trials will show similar results.
Reference
Source 89
For more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|